Compare Turning Point Brands (TPB) With Other Cannabis Stocks

Head-to-head stock comparisons across price, valuation, financials, and growth metrics

Company

Turning Point Brands (TPB)

Price

$90.62

Change

+0.69%

Market Cap

$1.73B

Sector

Ancillary

Ancillary Sector Peers

All Ancillary cannabis companies sorted by market capitalization. Click any ticker to see a detailed head-to-head comparison.

TickerNamePriceChange %MCap
SMGScotts Miracle-Gro$60.96+0.96%$3.54B
KERNAkerna Corp$6.27+24.64%$376.3M
LFLYLeafly Holdings$135.50+17.98%$271.0M
AGFYAgrify Corp$47.12+4.71%$94.2M
MAPSWM Technology (Weedmaps)$0.68-7.27%$73.0M
FORAForian Inc$2.05-0.97%$63.7M
GRWGGrowGeneration$1.06-2.75%$63.4M
GRAMFTPCO Holding (The Parent Company)$0.16-12.99%$45.7M
HYFMHydrofarm Holdings$1.19-6.30%$5.6M
GNLNGreenlane Holdings$0.82-1.84%$4.1M
FNNZFFinCanna Capital$0.00+38.10%$545.2K

Top Matchups by Market Cap

Companies closest to Turning Point Brands in market capitalization — the most meaningful head-to-head comparisons.

CURLFMSO

Curaleaf Holdings

MCap: $1.80B

$2.36+2.83%
Compare
GTBIFMSO

Green Thumb Industries

MCap: $1.54B

$6.56+7.01%
Compare
IIPRREIT

Innovative Industrial Properties

MCap: $1.48B

$52.66-2.34%
Compare
TCNNFMSO

Trulieve Cannabis

MCap: $1.22B

$6.40+4.92%
Compare
CRONLP

Cronos Group

MCap: $947.6M

$2.50+0.81%
Compare

Cross-Sector Comparisons

Top cannabis companies outside the Ancillary sector. Compare across different business models and market segments.

JAZZBiotech

Jazz Pharmaceuticals

MCap: $10.99B

$178.55-1.66%
Compare
CURLFMSO

Curaleaf Holdings

MCap: $1.80B

$2.36+2.83%
Compare
GTBIFMSO

Green Thumb Industries

MCap: $1.54B

$6.56+7.01%
Compare
IIPRREIT

Innovative Industrial Properties

MCap: $1.48B

$52.66-2.34%
Compare
TCNNFMSO

Trulieve Cannabis

MCap: $1.22B

$6.40+4.92%
Compare

Comparing TPB in the Cannabis Market

Turning Point Brands (TPB) is a Ancillary-sector cannabis company trading at $90.62 per share with a market capitalization of $1.73B. Among its Ancillary peers, TPB ranks #2 by market cap, with trailing twelve-month revenue of $463.1M and a gross margin of 55.9%. The stock has moved +0.69% in the current session, trading on the NYSE exchange.

When comparing TPB against other cannabis stocks, investors should consider key financial metrics including price-to-sales ratio (3.7x), revenue growth (0.00% YoY), and balance sheet strength (cash of $0 vs. debt of $0). The comparison tables above allow you to evaluate Turning Point Brands relative to 11 sector peers and leading companies across all cannabis sub-sectors, helping you identify which stocks offer better value, stronger growth, or more favorable risk profiles.

Frequently Asked Questions

How does TPB compare to other Ancillary stocks?+
Turning Point Brands has a market cap of $1.73B, placing it among 12 companies in the Ancillary sector. Its price-to-sales ratio is 3.7x and its gross margin is 55.9%. Use the table above to compare these metrics against every Ancillary peer.
What is TPB's biggest competitor?+
By market capitalization, the closest comparable company is Curaleaf Holdings (CURLF) with a market cap of $1.80B. Click the compare link to view a full head-to-head analysis.
Is TPB overvalued compared to its peers?+
Turning Point Brands trades at a P/S ratio of 3.7x. Compare this to sector peers in the table above to determine relative valuation. A lower P/S may indicate relative value, while a higher P/S may reflect growth expectations.
Which cannabis stock has better margins than TPB?+
Turning Point Brands has a gross margin of 55.9%. Among its Ancillary peers, 4 companies report higher gross margins. See the Sector Peers table for a full ranking.
Can I compare TPB to stocks in other cannabis sectors?+
Yes. The Cross-Sector Comparisons section above features top companies from sectors outside Ancillary. You can click any company to see a full side-by-side comparison with TPB covering price, valuation, financials, and growth metrics.

Related Pages

Disclaimer: The comparison data on this page is for informational purposes only and does not constitute financial advice, investment recommendations, or an endorsement of any security. Cannabis stocks are highly volatile and subject to unique regulatory risks. Always conduct your own research and consult a licensed financial advisor before making investment decisions.Cannabismarketcap does not guarantee the accuracy or completeness of any data presented.